Novartis (NOVN)

Basel-based pharmaceutical company created by the 1996 merger of Ciba-Geigy and Sandoz, now a pure-play innovative-medicines business after spinning off Alcon and Sandoz. Key franchises include cardiovascular, oncology and immunology drugs.

Legal name: Novartis AG
Ticker: NOVN
Exchange: SIX Swiss Exchange · MIC XSWX
Country: Switzerland
Sector: Healthcare
Industry: Pharmaceuticals
Market cap ≈: $230bn (approx., seed-0.4 · 2026-08-28)
Reporting currency: CHF
Founded: 1996
Website: www.novartis.com
LEI: 5493007HIVTX6SY6XD66 (GLEIF)
ISIN: CH0012005267 (check digit validated)
FIGI: BBG001SD31N7 (share class, OpenFIGI)

Graph connections view in graph →

lists_onSIX Swiss Exchange
domiciled_inSwitzerland

Sector peers — Healthcare

Eli Lilly · UnitedHealth Group · Johnson & Johnson · AbbVie · Merck & Co. · Thermo Fisher Scientific

Approximate reference values from public sources · seed-0.4 · 2026-08-28 · not real-time. See data & methodology.

# this page as data GET https://finance.foundation/api/v1/companies/novartis